Investors screening for speculative growth often encounter NCPL and ZBAO as two low-priced stocks with very different stories. Netcapital operates a digital private capital markets platform, while Zhibao Technology is a digital insurance brokerage serving China's market. Comparing them highlights how market positioning, revenue momentum, and risk factors shape relative performance. This stock comparison is most relevant to traders and investors who monitor micro-cap equities, are comfortable with elevated volatility, and want an objective view of how two financially strained but strategically repositioning companies stack up in the current market environment. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Netcapital Inc. is a fintech company whose platform lets private companies raise capital online, supported by a funding portal and a broker-dealer registered with the U.S. SEC and FINRA. In recent weeks, the company has emphasized a strategic pivot toward blockchain-based and tokenized assets, appointing a new chief executive and acquiring the assets of Rivetz, a hardware-security and blockchain technology firm. When I screened for similar fintech plays, Tickeron’s AI Trend Prediction Engine pointed to limited near-term momentum signals.
This repositioning has unfolded against weak financials. In its most recent reported quarter, total revenue fell to roughly $51,000 from about $170,500 a year earlier, driven by lower funding-portal activity, while the operating loss remained near $2.1 million. The net loss narrowed to $0.44 per share from $2.34, but the company disclosed limited cash and has previously noted going-concern language and SEC enforcement risk in its filings. These factors have contributed to elevated volatility, high short interest, and weak relative performance over the past year, with sentiment shaped by dilution concerns and uncertainty over whether the tokenization strategy can generate meaningful revenue.
Zhibao Technology Inc. is a China-based InsurTech company providing digital insurance brokerage through a "2B2C" embedded insurance model, powered by a proprietary PaaS platform. Its services span insurance brokerage and MGU functions, in which insurers authorize it to assist with underwriting, claims, and risk control.
Recent results show strong top-line momentum. For the fiscal year ended June 30, 2025, revenue increased roughly 51% to about RMB 276.9 million (about US$38.7 million), driven by a 57% rise in digital insurance brokerage revenue and higher GWP. However, elevated marketing and selling expenses pushed the company to a net loss of about RMB 62 million, versus a profit a year earlier. In the six months ended December 31, 2025, revenue rose about 41% year over year and the company returned to a small net profit, with gross margin improving to about 34.8%. Despite this operational progress, the stock has remained under pressure in recent weeks, reflecting broader sentiment toward small-cap China-listed equities and ongoing profitability questions.
The most fundamental contrast is business model and geography. NCPL is an early-stage capital-markets platform betting on a still-unproven transition into tokenized securities, with a shrinking revenue base and an SEC-related overhang. ZBAO, by contrast, operates an established digital brokerage with demonstrated revenue growth and an improving gross margin, though it carries China-specific regulatory and small-cap risks.
On momentum, the two diverge meaningfully. Zhibao has posted consistent double-digit revenue growth across recent periods and returned to marginal profitability in its latest half-year, suggesting a more coherent growth trajectory. Netcapital's revenue has contracted sharply, and its catalysts are largely forward-looking and dependent on successful execution in tokenization and its newly licensed broker-dealer, which had yet to generate revenue as of its most recent disclosures. From what I see, the steadier top-line story gives Zhibao an edge here.
On risk, both carry meaningful uncertainty. Netcapital's risks center on liquidity, dilution, and regulatory exposure, while Zhibao's risks include rising marketing costs, accounts-receivable quality, and the volatility common to Chinese micro-caps listed in the U.S. Neither offers a consistent profitability record, making this a comparison of a revenue-growing but unproven-profit insurer against a strategically pivoting but financially strained platform.
Based on observable factors, Tickeron's AI would likely lean toward ZBAO over NCPL in the current environment. Zhibao's combination of sustained revenue growth, improving gross margin, and a return to marginal profitability offers greater trend consistency and clearer fundamental support than Netcapital's declining revenue and reliance on unproven catalysts. That said, the verdict is probabilistic rather than definitive: Zhibao's shares remain vulnerable to cost pressures and sentiment swings in China-exposed small caps, while Netcapital's tokenization pivot could, if executed, change its trajectory quickly. A trend-following model would favor the steadier revenue story, but elevated volatility in both names argues for careful, data-driven position sizing. I'm watching this closely for any shifts in the data.
I often turn to Tickeron’s AI Trading Bots when evaluating volatile names like these. The platform offers hundreds of bots with performance stats, strategies, and risk metrics tailored to different market regimes, helping me compare options before committing capital. It is a practical way to add data-driven context to manual analysis without replacing judgment.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Experienced trader focused on market analysis, identifying trading opportunities, and developing custom trading signals based on market trends, price action, and data-driven insights. Join my Trader Club to follow my latest analysis, trading ideas, and active signals: https://tickeron.com/app/trader-club/103/view?tab=active§ion=trades&via=john
The Moving Average Convergence Divergence (MACD) for NCPL turned positive on November 11, 2026. Looking at past instances where NCPL's MACD turned positive, the stock continued to rise in 33 of 41 cases over the following month. The odds of a continued upward trend are 80%.
The Momentum Indicator moved above the 0 level on November 13, 2026. You may want to consider a long position or call options on NCPL as a result. In 72 of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 77%.
Following a +40.51% 3-day Advance, the price is estimated to grow further. Considering data from situations where NCPL advanced for three days, in 147 of 184 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
The Aroon Indicator entered an Uptrend today. In 64 of 87 cases where NCPL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 74%.
The 10-day RSI Indicator for NCPL moved out of overbought territory on November 20, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 24 similar instances where the indicator moved out of overbought territory. In 24 of the 24 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 31 of 34 cases where NCPL's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NCPL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
NCPL broke above its upper Bollinger Band on November 17, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. NCPL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 39 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 87 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.458) is normal, around the industry mean (3.143). P/E Ratio (-0.083) is within average values for comparable stocks, (6.733). Projected Growth (PEG Ratio) (0.090) is also within normal values, averaging (0.809). Dividend Yield (0.000) settles around the average of (8.975) among similar stocks. P/S Ratio (2.177) is also within normal values, averaging (17.075).
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NCPL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry InvestmentBanksBrokers